Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer.
Cazet AS, Hui MN, Elsworth BL, Wu SZ, Roden D, Chan CL, Skhinas JN, Collot R, Yang J, Harvey K, Johan MZ, Cooper C, Nair R, Herrmann D, McFarland A, Deng N, Ruiz-Borrego M, Rojo F, Trigo JM, Bezares S, Caballero R, Lim E, Timpson P, O'Toole S, Watkins DN, Cox TR, Samuel MS, Martín M, Swarbrick A.
Cazet AS, et al. Among authors: collot r.
Nat Commun. 2018 Jul 24;9(1):2897. doi: 10.1038/s41467-018-05220-6.
Nat Commun. 2018.
PMID: 30042390
Free PMC article.
Clinical Trial.